This research study is being done to gather information about how to do further clinical studies using AZD3355 as an add-on treatment to proton pump inhibitors (PPI).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
478
Symptom Intensity Rated by Participants Twice Daily Using an Electronic Reflux Symptom Questionnaire Diary
Symptom intensity rated on a six-graded Likert scale (Did not have; Very mild; Mild; Moderate; Moderately severe; Severe)
Time frame: Run-in period of 8-12 days and treatment period of 26-30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Athens, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Sherwood, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Los Angeles, California, United States
Research Site
Monterey, California, United States
Research Site
Murrieta, California, United States
Research Site
Orange, California, United States
Research Site
San Diego, California, United States
...and 74 more locations